New therapies for patients with complex conditions continue to increase, while employers and plan sponsors are seeking ways to help manage specialty spend and enhance care. Carelon leadership has highlighted three key strategies to improve specialty pharmacy care management, because, as noted in their recent article, “…specialty drugs often come at a high cost, and patients with diseases such as cancer, Crohn's disease, and multiple sclerosis (MS) who rely on these medications shouldn't have to struggle to access them.”
Carelon first emphasizes the importance of driving affordability, recommending measures such as implementing robust clinical utilization management and tracking the development of affordable biosimilars. Also underlined is the need to increase accessibility, suggesting the use of digital tools, trained care navigators, and a 24/7 care support system for members battling complex diseases. Lastly, Carelon stresses the significance of promoting collaboration among all stakeholders in healthcare, believing a collective approach is key to providing effective care through the pursuit of whole health.
Overall, these recommendations place patients at the center, focusing on creating actionable, positive changes for individuals reliant on specialty medications. Read the full article on Carelon.com to learn more about this vision.
You may also be interested in:
Help members save on prescriptions
Pipeline to prescription: CarelonRx formulary development
Plan for and manage your specialty spend
